NATIONAL
CANCER
INSTITUTE

NCI Cancer Bulletin
A Trusted Source for Cancer Research News
October 23, 2007 • Volume 4 / Number 28 E-Mail This Document  |  Download PDF  |  Bulletin Archive/Search  |  Subscribe


Bulletin Home

Featured Article
Decline in Cancer Death Rate Accelerating

Director's Update
With caBIG, the Cancer Community Goes "Interoperable"

Cancer Research Highlights
Trials Demonstrate Potential Role of HPV Screening Test

More Genetic Markers Found for Prostate Cancer Risk

Paclitaxel Benefit May Depend on HER2 Status

Batracylin Blocks DNA Replication in Cancer Cells

Special Report
Preventive Double Mastectomies Increasing Despite Some Concerns

FDA Update
New Chemotherapy Drug for Advanced Breast Cancer

Guest Commentary
Strengthening the Nation's Oncology Workforce

Featured Clinical Trial
Preventing Delayed Nausea in Breast Cancer Patients

Funding Opportunities

Notes
DCLG to Meet October 24-25

PLCO Etiology Study Seeks Applicants

YMCA and Armstrong Foundation Partner to Promote Wellness for Cancer Survivors

NCI Liaison Office Launches Web Site

New Patient Education Materials Available

Disparities Summit Report Available

NCI 70th Anniversary: If Memory Serves...

Cancer Center Profile
Case Comprehensive Cancer Center

Bulletin Archive

About the Bulletin

Page Options
Print This Page
Print This Document
View Entire Document
E-Mail This Document
View/Print PDF
Featured Article

Decline in Cancer Death Rate Accelerating

Cancer death rates are continuing their decline, researchers announced last week, and the downswing is actually picking up steam.

The new data - published in the Annual Report to the Nation produced by NCI, the Centers for Disease Control and Prevention, the American Cancer Society (ACS), and the North American Association of Central Cancer Registries - show a 2.1-percent decrease in cancer mortality rates between 2002 and 2004, an approximate doubling of the 1.1-percent decline seen each year from 1993 to 2002.  Read more  



Director's Update

Guest Update by Dr. Ken Buetow

Dr. Ken Buetow, NCI Associate Director for Bioinformatics and Information Technology With caBIG, the Cancer Community Goes "Interoperable"

The ability to connect people, organizations, and data through information technology is critical to fulfilling NCI's mission and to taking advantage of the research opportunities offered by 21st century science. Launched in 2004, the cancer Biomedical Informatics Grid (caBIG) was designed to be an information network that would allow the cancer research community to share data and knowledge and, in so doing, accelerate the discovery of new approaches to prevention, diagnosis, and treatment.

Earlier this year, the 3-year pilot phase of caBIG was successfully completed. That success was marked by the achievement of several important goals, most notably the participation of more than 1,000 individuals from over 190 organizations, and its use in several potentially high-impact research projects.  Read more  


The NCI Cancer Bulletin is produced by the National Cancer Institute (NCI). NCI, which was established in 1937, leads the national effort to eliminate the suffering and death due to cancer. Through basic, clinical, and population-based biomedical research and training, NCI conducts and supports research that will lead to a future in which we can identify the environmental and genetic causes of cancer, prevent cancer before it starts, identify cancers that do develop at the earliest stage, eliminate cancers through innovative treatment interventions, and biologically control those cancers that we cannot eliminate so they become manageable, chronic diseases.

For more information on cancer, call 1-800-4-CANCER or visit http://www.cancer.gov.

NCI Cancer Bulletin staff can be reached at ncicancerbulletin@mail.nih.gov.

Next Section >


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov